Corbus Pharmaceuticals (CRBP) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street ...

HC Wainwright reiterated their buy rating on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research report report published on Wednesday,Benzinga reports. The brokerage currently ...

Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at ...

William Blair analyst Andy Hsieh reiterated a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) today. The company’s shares opened today at $7.10. Effectively assess a stock's ...

Jefferies lowered the firm’s price target on Corbus Pharmaceuticals (CRBP) to $53 from $70 and keeps a Buy rating on the shares. The firm’s forecast for CRB-913 peak sales has been lowered to ...

NORWOOD, Mass. (AP) — NORWOOD, Mass. (AP) — Corbus Pharmaceuticals Holdings Inc. (CRBP) on Tuesday reported a loss of $9.5 million in its fourth quarter. The Norwood, Massachusetts-based ...

Since CEO Elon Musk went to Washington, Tesla's stock has tumbled nearly 48%. Since Elon Musk went to Washington, D.C., to slash the government alongside President Donald Trump, the stock of his ...

With rapid growth and the stock trading for about 21 times forward earnings, now could be a great opportunity. PayPal fell sharply after its latest earnings report disappointed growth-seeking ...

The U.S. stock market's sell-off is worsening Monday, and it's heading toward its worst day since 2022 as Wall Street questions how much pain President Donald Trump is willing for the economy to ...

The stock finally dropped into free fall today, plunging more than 15 percent to mark one of the company’s worst trading days since it went public in 2010. The tumble erased the last vestiges of ...